Hakan Koç

488 total citations
38 papers, 369 citations indexed

About

Hakan Koç is a scholar working on Hematology, Ophthalmology and Oncology. According to data from OpenAlex, Hakan Koç has authored 38 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 9 papers in Ophthalmology and 8 papers in Oncology. Recurrent topics in Hakan Koç's work include Hematopoietic Stem Cell Transplantation (15 papers), Glaucoma and retinal disorders (4 papers) and Acute Myeloid Leukemia Research (4 papers). Hakan Koç is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Glaucoma and retinal disorders (4 papers) and Acute Myeloid Leukemia Research (4 papers). Hakan Koç collaborates with scholars based in Türkiye, Iran and Italy. Hakan Koç's co-authors include Hamdi Akan, Muhıt Özcan, Osman İlhan, Günhan Gürman, Nahıde Konuk, Celalettin Üstün, Önder Arslan, Mutlu Arat, A. Uysal and Andrea Bacigalupo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

Hakan Koç

33 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hakan Koç Türkiye 10 216 96 75 66 56 38 369
Kun Soo Lee South Korea 12 287 1.3× 98 1.0× 71 0.9× 126 1.9× 43 0.8× 43 449
Laurence Clément France 13 167 0.8× 128 1.3× 127 1.7× 120 1.8× 37 0.7× 34 432
Aude Marie‐Cardine France 9 137 0.6× 73 0.8× 56 0.7× 112 1.7× 31 0.6× 24 414
D I Marks United Kingdom 10 153 0.7× 61 0.6× 74 1.0× 41 0.6× 22 0.4× 15 314
Takayuki Tabayashi Japan 12 108 0.5× 100 1.0× 74 1.0× 65 1.0× 55 1.0× 43 365
R Brown United States 12 371 1.7× 126 1.3× 47 0.6× 159 2.4× 76 1.4× 20 516
Pınar Ataca Atilla Türkiye 9 200 0.9× 186 1.9× 97 1.3× 65 1.0× 35 0.6× 18 383
Takahisa� Nakanishi Japan 11 125 0.6× 84 0.9× 59 0.8× 125 1.9× 12 0.2× 38 381
R Rokicka-Milewska Poland 12 188 0.9× 56 0.6× 111 1.5× 57 0.9× 70 1.3× 55 490
Luc Matthieu Fornecker France 9 64 0.3× 91 0.9× 48 0.6× 35 0.5× 31 0.6× 17 305

Countries citing papers authored by Hakan Koç

Since Specialization
Citations

This map shows the geographic impact of Hakan Koç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Koç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Koç more than expected).

Fields of papers citing papers by Hakan Koç

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakan Koç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Koç. The network helps show where Hakan Koç may publish in the future.

Co-authorship network of co-authors of Hakan Koç

This figure shows the co-authorship network connecting the top 25 collaborators of Hakan Koç. A scholar is included among the top collaborators of Hakan Koç based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakan Koç. Hakan Koç is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koç, Hakan, et al.. (2024). A potential biomarker for age-related macular degeneration disease: iris freckles. International Journal of Retina and Vitreous. 10(1). 62–62.
2.
Koç, Hakan, et al.. (2024). Effect of Tiotropium on eye findings in the treatment of chronic obstructive pulmonary disease. BMC Pulmonary Medicine. 24(1). 418–418. 1 indexed citations
3.
Koç, Hakan, et al.. (2023). Severe oculocardiac reflex during intravitreal injection. 32(4). 262–262.
4.
Koç, Hakan & Seza Özen. (2023). Efficacy of intravitreal dexamethasone in the treatment of frosted branch angiitis after mRNA-based COVID-19 vaccine. Journal Français d Ophtalmologie. 47(5). 104002–104002. 1 indexed citations
6.
Koç, Hakan, et al.. (2023). Does occupational radiation exposure affect retinal nerve fiber thickness?. International Ophthalmology. 43(12). 4831–4836.
7.
Soydan, Ender, Meral Beksaç, Hakan Koç, et al.. (2005). Imatinib only for molecular relapse is not sufficient to achieve a durable complete chimeric status and molecular remission after allo HCT in CML. Biology of Blood and Marrow Transplantation. 11(2). 25–25.
8.
Demirer, Taner, Meltem Aylı, Yavuz Selim Genç, et al.. (2003). High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Bone Marrow Transplantation. 31(9). 755–761. 5 indexed citations
9.
Demirer, Taner, Osman İlhan, Meltem Aylı, et al.. (2002). A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters. Bone Marrow Transplantation. 29(11). 893–897. 9 indexed citations
10.
11.
Gürman, Günhan, Harika Çelebi, Celalettin Üstün, et al.. (2001). Allogeneic Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia. Therapeutic Apheresis. 5(1). 54–57. 5 indexed citations
12.
Demirer, Taner, Osman İlhan, Mutlu Arat, et al.. (2001). CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. Journal of Clinical Apheresis. 16(2). 67–73. 15 indexed citations
13.
Özcan, Muhıt, Celalettin Üstün, Hamdi Akan, et al.. (2001). Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplantation. 27(5). 499–505. 16 indexed citations
14.
Beksaç, Meral, Cemaliye Boylu Akyerli, Mutlu Arat, et al.. (2001). Frequent demonstration of human herpesvirus 8 (HHV-8) in bone marrow biopsy samples from Turkish patients with multiple myeloma (MM). Leukemia. 15(8). 1268–1273. 13 indexed citations
15.
Gürman, Günhan, Mutlu Arat, Osman İlhan, et al.. (2001). Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies. Cytotherapy. 3(4). 253–260. 7 indexed citations
16.
Arslan, Önder, Mutlu Arat, Harika Çelebi, et al.. (2000). Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of İbni Sina Hospital. Bone Marrow Transplantation. 25(12). 1229–1232. 2 indexed citations
17.
Arslan, Önder, Hamdi Akan, Mutlu Arat, et al.. (2000). Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSF. Cytotherapy. 2(4). 259–265. 6 indexed citations
18.
Dılek, İmdat, Taner Demirer, Celalettin Üstün, et al.. (1998). Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. Bone Marrow Transplantation. 21(11). 1159–1161. 12 indexed citations
19.
Koç, Hakan, Hamdi Akan, Günhan Gürman, et al.. (1997). Hemorrhagic Cystitis as a Complication of Bone Marrow Transplantation. Journal of Chemotherapy. 9(1). 56–61. 11 indexed citations
20.
İlhan, Osman, Hamdi Akan, Hakan Koç, et al.. (1997). Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey. PubMed. 39(3). 133–136. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026